UB Paderborn / Katalog / Suche / in CDI

Albumin-targeting of an oxaliplatin-releasing platinum( iv ) prodrug results in pronounced anticancer activity due to endocytotic drug uptake in vivo

Chemical science (Cambridge), 2021-10, Vol.12 (38), p.12587-12599

2021

Link zum Volltext

Verfügbarkeit prüfen

The microRNA-200 family: still much to discover

Biomolecular concepts, 2016-12, Vol.7 (5), p.311-319

2016

Link zum Volltext

Verfügbarkeit prüfen

Signs and signals limiting myocardial damage using PICSO: a scoping review decoding paradigm shifts toward a new encounter

Frontiers in cardiovascular medicine, 2023-05, Vol.10, p.1030842-1030842

2023

Link zum Volltext

Verfügbarkeit prüfen

Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors

Cancers, 2022-04, Vol.14 (8), p.1936

2022

Link zum Volltext

Verfügbarkeit prüfen

Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10 years survival

ESC Heart Failure, 2023-12, Vol.10 (6), p.3559-3572

2023

Link zum Volltext

Verfügbarkeit prüfen

Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro

Oncology reports, 2016-11, Vol.36 (5), p.3065-3071

2016

Link zum Volltext

Verfügbarkeit prüfen

Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer

Journal of personalized medicine, 2023-07, Vol.13 (8), p.1186

2023

Link zum Volltext

Verfügbarkeit prüfen

Capecitabine and Trastuzumab in Heavily Pretreated Metastatic Breast Cancer

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3853-3858

2007

Link zum Volltext

Verfügbarkeit prüfen

Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers

Cancers, 2020-11, Vol.12 (11), p.3381

2020

Link zum Volltext

Verfügbarkeit prüfen

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920938611-1758835920938611

2020

Link zum Volltext

Verfügbarkeit prüfen

Precision Medicine for the Management of Therapy Refractory Colorectal Cancer

Journal of personalized medicine, 2020-12, Vol.10 (4), p.272

2020

Link zum Volltext

Verfügbarkeit prüfen

OncomiR-17-5p: alarm signal in cancer?

Oncotarget, 2017-09, Vol.8 (41), p.71206-71222

2017

Link zum Volltext

Verfügbarkeit prüfen

Gender differences in molecular‐guided therapy recommendations for metastatic malignant mesothelioma

Thoracic cancer, 2020-07, Vol.11 (7), p.1979-1988

2020

Link zum Volltext

Verfügbarkeit prüfen

Indocyanine green video angiography predicts outcome of extravasation injuries

PloS one, 2014-08, Vol.9 (8), p.e103649-e103649

2014

Link zum Volltext

Verfügbarkeit prüfen

Extravasation emergencies: state-of-the-art management and progress in clinical research

Memo - Magazine of European medical oncology, 2016-12, Vol.9 (4), p.226-230

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9

European journal of clinical pharmacology, 2021-10, Vol.77 (10), p.1473-1484

2021

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Double-Blind, Parallel, Single-Site Pilot Trial to Compare Two Different Starting Doses of Methotrexate in Methotrexate-Naïve Adult Patients with Rheumatoid Arthritis

Clinical therapeutics, 2012-05, Vol.34 (5), p.1195-1203

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTI

Journal of personalized medicine, 2020-10, Vol.10 (4), p.188

2020

Link zum Volltext

Verfügbarkeit prüfen

Loss of miR-200 family in 5-fluorouracil resistant colon cancer drives lymphendothelial invasiveness in vitro

Human molecular genetics, 2015-07, Vol.24 (13), p.3689

2015

Link zum Volltext

Verfügbarkeit prüfen

Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases

Clinical cancer research, 2019-05, Vol.25 (9), p.2737-2744

2019

Link zum Volltext

Verfügbarkeit prüfen

MALDI-MS Protein Profiling of Chemoresistance in Extracellular Vesicles of Cancer Cells

Analytical chemistry (Washington), 2018-11, Vol.90 (22), p.13178-13182

2018

Link zum Volltext

Verfügbarkeit prüfen

Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca2+ signalling

Cellular and molecular life sciences : CMLS, 2017-05, Vol.74 (10), p.1907-1921

2017

Link zum Volltext

Verfügbarkeit prüfen

High impact of miRNA-4521 on FOXM1 expression in medulloblastoma

Cell death & disease, 2019-09, Vol.10 (10), p.696-15, Article 696

2019

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal biomonitoring of nurses handling antineoplastic drugs

Journal of clinical nursing, 2009-01, Vol.18 (2), p.263-269

2009

Link zum Volltext

Verfügbarkeit prüfen

Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing

Scientific reports, 2018-01, Vol.8 (1), p.124, Article 124

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Albumin-targeting of an oxaliplatin-releasing platinum( iv ) prodrug results in pronounced anticancer activity due to endocytotic drug uptake in vivo

The microRNA-200 family: still much to discover

Signs and signals limiting myocardial damage using PICSO: a scoping review decoding paradigm shifts toward a new encounter

Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors

Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10 years survival

Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro

Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer

Capecitabine and Trastuzumab in Heavily Pretreated Metastatic Breast Cancer

Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma

Precision Medicine for the Management of Therapy Refractory Colorectal Cancer

OncomiR-17-5p: alarm signal in cancer?

Gender differences in molecular‐guided therapy recommendations for metastatic malignant mesothelioma

Indocyanine green video angiography predicts outcome of extravasation injuries

Extravasation emergencies: state-of-the-art management and progress in clinical research

A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9

A Randomized, Double-Blind, Parallel, Single-Site Pilot Trial to Compare Two Different Starting Doses of Methotrexate in Methotrexate-Naïve Adult Patients with Rheumatoid Arthritis

Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTI

Loss of miR-200 family in 5-fluorouracil resistant colon cancer drives lymphendothelial invasiveness in vitro

Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases

MALDI-MS Protein Profiling of Chemoresistance in Extracellular Vesicles of Cancer Cells

Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca2+ signalling

High impact of miRNA-4521 on FOXM1 expression in medulloblastoma

Longitudinal biomonitoring of nurses handling antineoplastic drugs

Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing

Suchergebnisse filtern